Stay updated on Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 entry was added to the record history, and a lengthy government funding status notice was removed from the page header. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-11T09:18:15.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and NIH Clinical Center status, and updated the record history to Revision: v3.4.1 while removing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-04T05:15:07.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    UI enhancements include a glossary display option, color-coded change indicators, and an updated revision label.
    Difference
    1%
    Check dated 2026-01-28T02:40:45.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Record history updated with a new revision entry (v3.3.4) and removal of the previous revision entry (v3.3.3); to avoid alerts for minor changes, set an alert condition.
    Difference
    0.1%
    Check dated 2026-01-14T01:32:52.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    New entries in Record History include a Completed status dated 2025-12-19 and Study Status/Recruitment Status updates on 2025-12-18 (Revision: v3.3.3). Older status details and the HHS Vulnerability Disclosure line were removed.
    Difference
    2%
    Check dated 2025-12-23T17:16:25.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    Revision v3.3.2 has been added to the Record History, and Revision v3.2.0 has been removed from the list.
    Difference
    0.1%
    Check dated 2025-11-24T17:51:44.000Z thumbnail image

Stay in the know with updates to Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial page.